STOCK TITAN

L1 Capital now holds 1.79% GeoVax Labs (GOVX) passive stake

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

L1 Capital Global Opportunities Master Fund, Ltd. filed an amended Schedule 13G reporting beneficial ownership of 547,715 GeoVax Labs common stock equivalents as of 12/31/2025. These relate to warrants to purchase common stock acquired in July, September, and December 2025 private transactions.

The position represents 1.79% of GeoVax’s common stock class, based on 30,058,786 shares outstanding from a Form S-1. L1 Capital has sole voting and dispositive power over all 547,715 shares and certifies the holdings are not for the purpose of changing or influencing control of GeoVax.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



L1 Capital Global Opportunities Master Fund, Ltd.
Signature:/s/ David Feldman
Name/Title:David Feldman, Director
Date:02/17/2026

FAQ

What stake in GeoVax Labs (GOVX) does L1 Capital report?

L1 Capital Global Opportunities Master Fund reports beneficial ownership of 547,715 GeoVax Labs common stock equivalents. This represents 1.79% of the company’s common stock, calculated using 30,058,786 shares outstanding referenced from a GeoVax Form S-1.

What type of securities does L1 Capital hold in GeoVax Labs (GOVX)?

L1 Capital’s reported position consists of warrants to purchase GeoVax common stock. The 547,715 beneficially owned securities reflect warrants acquired in July, September, and December 2025, which are treated as common stock equivalents under Rule 13d-3.

How is L1 Capital’s 1.79% GeoVax (GOVX) ownership percentage calculated?

The 1.79% ownership is based on 30,058,786 GeoVax common shares outstanding. This share count comes from the company’s Form S-1 registration statement filed on December 12, 2025, which the reporting person uses as the denominator for its percentage.

Does L1 Capital control voting and disposition of its GeoVax (GOVX) holdings?

The fund reports sole voting power and sole dispositive power over all 547,715 common stock equivalents. It reports no shared voting or dispositive power, indicating decisions over these securities are made solely by the reporting person entity.

Is L1 Capital’s GeoVax (GOVX) filing a passive investment certification?

Yes. The filing certifies the GeoVax securities were not acquired and are not held to change or influence control of the issuer. It also states they are not held in connection with any control-related transaction, other than activities tied to a specific nomination rule.

Who are the individuals associated with L1 Capital’s GeoVax (GOVX) position?

The filing identifies David Feldman and Joel Arber as directors of L1 Capital Global Opportunities Master Fund, Ltd. It notes they may be deemed beneficial owners under Rule 13d-3 but each disclaims beneficial ownership of the GeoVax securities for all other purposes.
Geovax Labs Inc

NASDAQ:GOVX

GOVX Rankings

GOVX Latest News

GOVX Latest SEC Filings

GOVX Stock Data

2.91M
415.51k
Biotechnology
Pharmaceutical Preparations
Link
United States
SMYRNA